Fig. 2From: Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancerOverall survival curves by the Kaplan–Meier method in definitive and salvage CRTBack to article page